Ester Research Articles

Biosynthesis of Nonribosomal Peptides Chitinimides Reveal a Special Type of Thioesterase Domains.

Non-ribosomal peptide synthetases (NRPSs) and their tailored enzymes have diverse biological functions. In this study, we investigated the biosynthesis and function of chitinimides, which belong to the non-ribosomal peptide (NRP) subfamily featuring a pyrrolidine-containing part (X part) connected to the polypeptide chain via an ester bond. A conserved gene cassette, chmHIJK, is responsible for oxyacylation of the pyrrolidine moiety in the X part. The thioesterase (TE) domain of ChmC (ChmC-TE) catalyzes transesterification reactions with a free X part or methanol as a nucleophilic reagent to form different chitinimides. The crucial amino acid residues in the ChmC-TE domains responsible for the specific recognition of the X part were identified, and they were conserved in all the biosynthetic pathways of this NRP subfamily to form a signature motif, YNHNR, suggesting a special type of TE domain in NRPSs. Chitinimides demonstrate the biological function of promoting the swarming ability of the native producer. This study provides deep insights into the biosynthesis of this special NRP subfamily, and shows that the special TE domain could be used to generate diverse NRPs by combinatorial biosynthesis.

In-situ Forming Multipolymeric Glucose-Responsive Hydrogels.

Stimuli-responsive hydrogels (HGs) have shown promise for smart drug delivery applications. Specifically, glucose-responsive HGs having phenylboronic acid (PBA) functional groups are extensively pursued for insulin delivery in hyperglycemia. Current polymeric glucose-responsive HGs are cumbersome to fabricate and show a limited insulin release profile. Herein, we develop a straightforward fabrication of glucose-responsive multipolymer HGs (MPHGs) using a three-component in situ mixing. Molecular cargo, such as insulin, was loaded during the gelation. Heterobifunctional formylphenylboronic acid (FPBA) crosslinkers were used to interconnect polyvinyl alcohol (PVA) and branched polyethyleneimine (PEI) via boronate ester and imine bonds, respectively. Three positional isomers of FPBA (2FPBA, 3FPBA, and 4FPBA) resulted in HGs with distinct viscoelastic behaviors under the same conditions. HGs derived from 4FPBA exhibited more solid-like properties compared to 2FPBA and 3FPBA due to a higher crosslinking density. All the HGs exhibited glucose-responsive dissolution and release of embedded insulin cargo without disrupting the native structure. Insulin release profiles show a higher glucose-responsive release from 4FPBA-derived MPHGs. All the HGs were injectable, self-healing, and noncytotoxic below 10 μg/ml concentrations. The MPHGs developed in this study uncover new directions in creating glucose-responsive matrices for self-regulating drug delivery applications. In the future, detailed in vivo studies will be performed for clinical applications.

An Advanced Hydrogel Dressing System with Progressive Delivery and Layer-to-Layer Response for Diabetic Wound Healing.

Wound healing in diabetic patients presents a significant challenge due to delayed inflammatory responses, which obstruct subsequent healing stages. In response, we have developed a progressive, layer-by-layer responsive hydrogel, specifically designed to meet the dynamic requirements of diabetic wounds throughout different healing phases. This hydrogel initiates with a glucose-responsive layer formed by boronate ester bonds between 4-arm-poly (ethylene glycol) succinimidyl glutarate (4arm-PEG-SG) and 3-aminophenylboronic acid. This configuration ensures precise control over the physicochemical properties, facilitating accurate drug release during the healing process. Furthermore, we have incorporated an active pharmaceutical ingredient ionic liquid (API) composed of diclofenac and L-carnitine. This combination effectively tackles the solubility and stability issues commonly associated with anti-inflammatory drugs. To further refine drug release, we integrated matrix metalloproteinase-9 (MMP-9)-sensitive gelatin microcapsules, ensuring a controlled release and preventing the abrupt, uneven drug distribution often seen in other systems. Our hydrogel's rheological properties closely resemble human skin, offering a more harmonious approach to diabetic wound healing. Overall, this progressive layer-by-layer responsive wound management system, which is a safe, efficient, and intelligent approach, holds significant potential for the clinical treatment of diabetic wounds. STATEMENT OF SIGNIFICANCE: The two main problems of diabetic wounds are the long-term infiltration of inflammation and the delayed repair process. In this experiment, a glucose-responsive hierarchical drug delivery system was designed to intelligently adjust gel properties to meet the needs of inflammation and repair stage of wound healing, accelerate the transformation of inflammation and repair stage, and accelerate the process of repair stage. In addition, in order to achieve accurate drug release in anti-inflammatory layer hydrogels and avoid sudden drug release due to poor solubility of anti-inflammatory small molecule drugs, we constructed a ionic liquid of active pharmaceutical ingredients (API-ILs) using diclofenac and L-carnitine as raw materials. It was wrapped in MMP-9 enzyme active gelatin microcapsule to construct a double-reaction anti-inflammatory layer gel to achieve accurate drug release. These findings highlight the potential of our system in treating diabetic wounds, providing a significant advance in wound treatment.

One-pot Hydrogenolysis of Polyethylene Terephthalate (PET) to p-xylene over CuZn/Al2O3Catalyst.

Chemical upcycling of plastic wastes into valuable chemicals is a promising strategy for resolving plastic pollution, but economically viable methods currently are still lacking. Here, we report one-pot hydrogenolysis of PET plastic into p-xylene with an excellent yield (99.8 %) over a robust non-precious Cu-based catalyst, CuZn/Al2O3, in the absence of alcohol solvents. The presence of Zn species promotes the dispersion of Cu0 and increases the ratio of Cu+/Cu0, whereas the synergistic effect of Cu0 and Cu+ leads to a superior performance in the conversion of PET. The combination of GC-MS, 13C CP MAS NMR, 2D 1H-13C CP HETCOR NMR spectroscopy and kinetic studies for the first time demonstrates 4-methyl benzyl alcohol as an important reaction intermediate in the hydrogenolysis of PET. Mechanistic studies indicate that the conversion of PET mainly follows a hydrogenolysis process, involving the cleavage of ester bonds to alcohols and the C-O bond cleavage of alcohols to alkanes. This work not only brings new insight for understanding the upgrading pathway of PET, but also provides a guidance for the design of high-performance non-precious catalysts for the chemical upcycling of plastic wastes.

Novel visible-light-driven antibacterial film grafted with 3,3,4,4-benzophenone tetracarboxylic acid (BPTCA) for chilled meats preservation

To improve long-term stability and low-toxicity active packaging systems, three visible-light-driven antibacterial packaging films from chitosan (CS), silk fibroin (SF), polyvinyl alcohol (PVA) and 3,3,4,4-benzophenone tetracarboxylic acid (BPTCA) were fabricated in this study. First, CS/PVA, SF/PVA and CS/SF/PVA films by solution casting method, and enhance their water solubility by glutaraldehyde (GA) cross-linking to obtain CS/PVA-G, SF/PVA-G and CS/SF/PVA-G. Then, BPTCA was covalently immobilized onto CS/PVA-G, SF/PVA-G and CS/SF/PVA-G through the esterification to obtain CS/PVA-B, SF/PVA-B and CS/SF/PVA-B, respectively. The chemical structure, photophysical properties, and antibacterial capacities are characterized. The FTIR revealed that BPTCA is covalently grafted with the polymer matrix via ester bond. Furthermore, grafting of BPTCA enhanced the film's UV-blocking, decreased water contact angle, water vapor permeability, and possessed moderate mechanical properties. Meanwhile, CS/SF/PVA-B has the best reactive oxygen species generation ability and antibacterial activity (against Escherichia coli, Staphylococcus aureus, Salmonella enteritidis), and can recycle four times, overall migration value of BPTCA was within the limits of 10 mg/dm2. We apply CS/SF/PVA-B films combined with palletized packaging to different chilled-meat preservation applications, and measure physicochemical changes and microbial counts. Shelf lives of chilled mutton are extended by 3 d and chicken by 6 d, compared with controls without CS/SF/PVA-B film. A covalent immobilized visible-light-driven antibacterial packaging may improve the long-term quality of chilled meats.

Self-assembled nanoparticles of alginate and paclitaxel-triphenylphosphonium for mitochondrial apoptosis targeting.

Paclitaxel (PTX), an antimitotic drug from the taxanes group, prevents the proliferation of breast cancer cells through mitosis arrest and activation by a cascade of signaling pathways that lead to apoptosis. Mitochondria is one of the important signaling routes for inducing apoptosis. For mitochondria targeting, triphenylphosphonium (TPP) with a delocalized charge and hydrophobic nature was utilized as a moiety to facilitate penetration through a phospholipid membrane of mitochondria. PTX-TPP was synthesized via pH-sensitive ester bond between hydroxyl groups of PTX and carboxylic acid of (4-carboxybutyl) TPP. Then PTX-TPP prodrug encapsulated in alginate nanoparticles, which were self-assembled by the ionotropic complexation technique for enhancement of mitochondrial apoptosis in breast cancer cells. The loading of PTX-TPP conjugation in self-assembled alginate nanoparticles was 16.5% and the particle size of nanoparticles was 123nm with zeta potential around -25.8 Mv. The in vitro cytotoxicity and IC50 of PTX-TPP nanoparticles in the growth of MCF7 cancer cell increased 6.3-fold higher than free PTX. The early apoptotic cells and the late apoptotic/necrotic cells for PTX-TPP nanoparticles were 11.6 and 3.9-fold higher than free PTX. This study indicated this mitochondrial-targeted self-assembled nanoparticles can inhibit the tumor cell growth of breast cancer.

Synthesis and Mass Spectrometry Structural Assessment of Polyesteramides Based on ε-Caprolactone and L-Phenylalanine

L-Phenylalanine-ε-caprolactone-based polyesteramides (PCPs) were synthesized via melt polycondensation across a diverse range of molar compositions. The copolymer structure was extensively characterized using nuclear magnetic resonance (NMR) and matrix-assisted laser desorption/ionization mass spectrometry (MALDI MS). NMR analysis confirmed the intercalation of the L-Phenylalanine comonomer units within the polyester backbone. MALDI MS characterization further demonstrated the formation of linear PCP chains with carboxyl end groups. A detailed structural analysis through MALDI MS/MS fragmentation indicated that ester bond scission was the predominant fragmentation mechanism, depicting the polyesteramide sequence in the copolymers. The resulting copolymers were primarily amorphous, except for those with molar compositions of 90/10 and 80/20, which exhibited semi-crystalline structures. Additionally, these PCPs showed an increase in glass transition temperatures with higher amino acid contents and demonstrated good thermal stabilities, as evidenced by a 10% mass loss at elevated temperatures.

Sphingomyelin Inhibits Hydrolytic Activity of Heterodimeric PLA2 in Model Myelin Membranes: Pharmacological Relevance.

In this work, the heterodimeric phospholipase A2, HDP-2, from viper venom was investigated for its hydrolytic activity in model myelin membranes as well as for its effects on intermembrane exchange of phospholipids (studied by phosphorescence quenching) and on phospholipid polymorphism (studied by 1H-NMR spectroscopy) to understand the role of sphingomyelin (SM) in the demyelination of nerve fibers. By using well-validated in vitro approaches, we show that the presence of SM in model myelin membranes leads to a significant inhibition of the hydrolytic activity of HDP-2, decreased intermembrane phospholipid exchange, and reduced phospholipid polymorphism. Using AutoDock software, we show that the NHδ+ group of the sphingosine backbone of SM binds to Tyr22(C=Opbδ-) of HDP-2 via a hydrogen bond which keeps only the polar head of SM inside the HDP-2's active center and positions the sn-2 acyl ester bond away from the active center, thus making it unlikely to hydrolyze the alkyl chains at the sn-2 position. This observation strongly suggests that SM inhibits the catalytic activity of HDP-2 by blocking access to other phospholipids to the active center of the enzyme. Should this observation be verified in further studies, it would offer a tantalizing opportunity for developing effective pharmaceuticals to stop the demyelination of nerve fibers by aberrant PLA2s with overt activity - as observed in brain degenerative diseases - by inhibiting SM hydrolysis and/or facilitating SM synthesis in the myelin sheath membrane.

Adhesive lipophilic gels delivering rapamycin prevent oral leukoplakia from malignant transformation

Oral leukoplakia (OLK) is the most emblematic oral potentially malignant disorder that may precede the diagnosis of oral squamous cell carcinoma (OSCC) and has an overall malignant transformation rate of 9.8 %. Early intervention is crucial to reduce the malignant transformation rate from OLK to OSCC but the lack of effective local pharmaceutical preparations poses a challenge to clinical management. Rapamycin is speculated to prevent OLK from carcinogenesis and its inherent lipophilicity facilitates its penetration into stratum corneum. Nevertheless, hydrophilic hydrogels frequently encounter challenges when attempting to deliver lipophilic drugs. Furthermore, the oral cavity presents a complex environment defined by oral motor functions, saliva secretion cycles, dynamic fluctuations, and protective barriers comprising mucus and lipid layers. Consequently, addressing issues of muco-penetration and muco-adhesion is imperative for developing an effective drug delivery system aiming at delivering rapamycin to target oral potentially malignant disorders.Here, a dual-function hydrogel drug delivery system integrating adhesion and lipophilicity was successfully developed based on polyvinyl alcohol (PVA) and dioleoyl phosphatidylglycerol (DOPG) via dynamic boronic ester bonds. Rheological experiments based on orthogonal design revealed that PVA-DOPG hydrogels exhibited ideal adhesive strength (around 6 kPa) and could adhere to various surfaces in both dry and wet conditions. PVA-DOPG hydrogels also significantly promoted lipophilic molecules’ penetration into stratum corneum (integrated fluorescence density of 6.95 ± 0.52 × 106 and mean fluorescence depth of 0.96 ± 0.07 mm) of ex-vivo porcine buccal mucosa (p < 0.001). Furthermore, PVA-DOPG hydrogels incorporating rapamycin inhibited malignant transformation of OLK mouse model induced by 4-Nitroquinoline N-oxide (4-NQO), distinct improvements in survival (the neoplasm incidence density at the 40th day is 0.0091) (p < 0.05), decrease in neoplasm incidence density of 36.36 % and inhibition rate in neoplasm volume of 75.04 ± 33.67 % have been demonstrated, suggesting the hydrogels were valuable candidates for potential applications in the management of OLK.

A Multi-Responsive Hydrogel Combined With Mild Heat Stimulation Promotes Diabetic Wound Healing by Regulating Inflammatory and Enhancing Angiogenesis.

The repair of diabetic wound still encounters huge challenges, such as disordered inflammatory regulation and impaired neovascularization. Here, a pH/ROS/glucose responsive and photothermal hydrogel is developed for diabetic wound healing. The hydrogel is formed through cross-linkage between phenylboronic acid-modified carboxymethyl chitosan (CMCS-PBA) and oxide dextran (OXD), utilizing Schiff base and phenylboronate ester bonds. Additionally, insulin-like growth factor 1 C domain (IGF-1C) and deferoxamine-loaded polydopamine nanoparticles (D@P) are incorporated into the hydrogel. The hydrogel demonstrates sustained drug release, excellent photo thermal effect, prominent antioxidant, antibacterial and anti-inflammatory activities, desirable mechanical and tissue adhesive properties, enhanced tube formation, and cell migration. Furthermore, the hydrogel combined with mild heat treatment can regulate chronic inflammation by promoting the transformation of macrophages from M1 phenotype to M2 phenotype and enhance angiogenesis by up-regulating the expression levels of angiogenesis-related factors such as hypoxia-inducible factor-1 alpha (HIF-1α), vascular endothelial growth factor (VEGF), CD31, and α-SMA, thus greatly accelerates the wound healing in streptozotocin (STZ)-induced diabetic mice. Therefore, this multi-responsive and multifunctional hydrogel holds potential as a therapeutic strategy for diabetic wounds.

A Cell-Free Kinetic Analysis of Ionizable Lipid Hydrolysis.

The prolonged retention of ionizable lipids within the body limits the repeated dosing of lipid nanoparticles (LNPs) for nucleic acid delivery. While most ionizable lipids are primarily metabolized in the liver via the enzymatic hydrolysis of ester bonds, elimination half-lives can range from several hours to days. The development of compounds that undergo rapid biodegradation remains a major engineering challenge in the absence of standardized biodegradability assessments in the early stages of drug discovery. Here, we analyze and compare the hydrolysis kinetics of well-known ionizable lipids (ALC-0315, DLin-MC3-DMA, LP-01, L319, and SM-102) using optimized cell-free reactions monitored by 1H NMR. Unlike conventional analytical techniques, these NMR-based methods are universal and suitable for high-throughput screening. We demonstrate that enzyme-catalyzed and base hydrolysis reactions can predict whether ionizable lipids undergo fast or slow liver elimination, as our results are in alignment with prior pharmacokinetic studies. Furthermore, we show that the hydrolysis kinetics of ionizable lipids vary by several orders of magnitude depending on steric effects. This study provides a framework to expedite the discovery of rapidly degradable ionizable lipids, with implications for improving the therapeutic index of LNP-based drugs.

Fabrication of PBAT/lignin composite foam materials with excellent foaming performance and mechanical properties via grafting esterification and twin-screw melting free radical polymerization

As one of the mainstream biodegradable materials, poly(butylene adipate-co-terephthalate) (PBAT) foams offer a sustainable alternative to traditional plastic foams, effectively reducing environmental pollution. However, the high cost and poor mechanical performance of PBAT foams impede their practical application. Herein, the glycidyl methacrylate-grafted biomass lignin (GML) was used to produce a PBAT/GML composite foam with good foaming performance and mechanical properties at high lignin-filling amounts by twin-screw melting free radical polymerization and supercritical CO2 foaming process. The compatibility of GML in the PBAT matrix was improved due to the formation of ester bonds in modified lignin, endowing the PBAT/GML (PGML) composite foam with exceptional foaming performance. Additionally, the mechanical properties of PGML composite foam were remarkably enhanced due to the introduction of the abundant aromatic structures of GML and the construction of a stable covalent crosslinking network. The compressive strengths and compression modulus of the PGML foam were improved by 2.53 times and 2.47 times, while its bending strength and bending modulus were improved by 1.27 times and 3.92 times compared to the neat PBAT. This research affords a new strategy for developing low-cost biodegradable biomass PBAT/lignin composite foam materials with good foaming performance and mechanical properties.Graphical abstract

Ultra-Stretchable, Adhesive, Conductive, and Antifreezing Multinetwork Borate Ester-Based Hydrogel for Wearable Strain Sensor and VOC Absorption.

Hydrogels based on borate ester bonds exhibit remarkable tensile strength and self-healing ability, which make them a promising material for various biological research and strain sensor applications. However, in order to meet the practical application of hydrogel strain sensors, they must also show high conductivity, frost resistance, and proper adhesion, which is still a continuous challenge. Herein, a triple network hydrogel was prepared using poly(vinyl alcohol) (PVA) as the first network, ethylene imine polymer (PEI) as the second network, and poly(acrylamide-co-acrylic acid) copolymer (denoted as P(AM-Co-AA)) as the third network. 3-Carboxy-4-fluorophenylboronic acid (CFBS) was used as the cross-linking agent, glycerol (GL) was added to improve low-temperature resistance, and sodium chloride (NaCl) was incorporated to enhance electrical conductivity. The resulting PVA-CFBS@PEI@P(AM-Co-AA) triple network hydrogel exhibited impressive mechanical properties, including ultra tensile strength (4100%, 266.8 kPa), high toughness (6.5 MJ/m3), and low-temperature resistance (-60 °C). Additionally, it demonstrated high conductivity (σ = 1.83 mS/cm). The incorporation of CFBS endowed the hydrogel with excellent self-healing ability, while GL improved low-temperature resistance and strain sensing sensitivity (gauge factor (GF) = 2.8 (0-300%), GF = 5.6 (300-600%), GF = 8.7 (600-1000%)). The prepared hydrogel sensor can repetitively detect and differentiate between a wide range of human activities such as joint movements, frowning, and smiling. Additionally, the hydrogel demonstrated favorable mechanical properties at -20 °C (good adhesion, tensile strength: 1169.8%, 1.2 MPa; conductivity: 0.71 mS/cm, and strain sensing coefficient: GF = 1.3), making it suitable for applications in low-temperature environments. Furthermore, it also functions as an exceptional adsorbent, capable of selectively absorbing volatile organic compounds at high capacity (e.g., methanol: 1.80 g/g; acetone: 1.50 g/g).

Facial Amphiphile-Modified Lipids Highly Sensitize Liposomes toward Secretory Phospholipase A2.

Upregulated secretory phospholipase A2 (sPLA2) in tumors has been proposed as a stimulus to trigger drug release from liposomes for therapeutic effects. However, the current strategy for developing sPLA2-responsive liposomes merely considering substrate preference suffers from limited membrane disruptive effects induced by enzymatic hydrolysis and safety issues resulting from the overuse of sPLA2-preferred lipids. Here, a membrane-destabilizing mechanism based on enzymatic extraction and the transition of facial amphiphiles (FAs) within lipid membranes was introduced. Enzymatic degradation of FA-modified lipids, a process involving substrate extraction of lipids from membranes and cleavage of sn-2 ester bonds by sPLA2, rotation, and interface settling of detached FAs, caused tremendous efflux of payloads from liposomes, termed the SECRIS effect. In the presence of sPLA2, oxaliplatin (L-OHP) loaded liposomes containing FA-modified lipids showed enhanced drug release, comparable in vitro cytotoxicity, and excellent in vivo antitumor efficacy and reduced adverse syndromes in Colo205-bearing mice compared to conventional sPLA2-labile formulations. The discovery of the SECRIS effect creates a new pathway to engineer liposome platforms for the treatment of sPLA2-positive tumors.

EDTA‐modified cellulose from sago bark (Metroxylon sagu) for anionic and cationic dyes removal

AbstractThe present research employed ethylenediaminetetraacetic (EDTA) modified cellulose to remove basic violet 10 (BV10) and reactive orange 16 (RO16) dyes. The cellulose was obtained from sago bark which was solid waste of sago starch industries. Sago bark contains 56.86% cellulose so that it can provide significant amount of active site. The optimum condition was examined using batch method investigating some parameters including pH, initial dye concentration, contact time, and thermodynamics. The adsorption capacity of cellulose (Cell) itself was also investigated for the comparison. The characterization of adsorbent showed the presence of ester bond, amine groups and escalating of surface area and pores after EDTA modification. The adsorption capacity of EDTA‐modified cellulose (Cell‐EDTA) was 73.53 mg/g for BV10 and 22.42 mg/g for RO16. The adsorption of both dyes onto Cell‐EDTA followed Langmuir isotherm model and pseudo‐second‐order kinetic model. Thermodynamic parameters indicated that the adsorption process was spontaneous, endothermic and feasible. Desorption studies proved that NaOH was an effective desorbing agent of BV10 and RO16. Based on research, Cell‐EDTA was more favorable in cationic dye, basic violet 10 than anionic dye, reactive orange 16.

ROS-responsive injectable hydrogels loaded with exosomes carrying miR-4500 reverse liver fibrosis

The reversal of liver fibrosis requires effective strategies to reduce oxidative stress and inhibition of hepatic stellate cell (HSC) activation. MiR-4500 regulates pathological angiogenesis and collagen mRNA stability, with the potential to inhibit fibrosis. Herein, we explored the inhibition of HSC activation in vitro by exosomes (Exos) carrying miR-4500 and encapsulated ExosmiR−4500 in an intelligent injectable hydrogel with biological activity and reactive oxygen species (ROS) responsiveness for application in oxidative stress environments. Briefly, reversible boronic ester bonds were integrated into gelatin-based hydrogels through dynamic crosslinking of quaternized chitosan (QCS) and 4-carboxyphenylboronic acid (CPBA)-modified gelatin. The QCS-CPBA-Gelatin (QCG) hydrogel scavenged excess ROS from the local microenvironment and released ExosmiR−4500 through the dissociation of boronic ester bonds, providing a favorable microenvironment and in situ sustained-release drug delivery system for ExosmiR−4500. The results showed that QCG@ExosmiR−4500 hydrogel has biocompatibility, biodegradability, and slow-release ability, which could effectively clear ROS and inhibit HSC activation and pathological angiogenesis in vitro and in vivo. Furthermore, transcriptome analysis suggests that the pharmacological mechanism of the QCG@ExosmiR−4500 hydrogel is mainly related to anti-oxidation, anti-angiogenesis, anti-fibrosis processes, and signaling pathways. Thus, our study demonstrates that an intelligently responsive ExosmiR−4500 delivery system based on injectable hydrogels is a promising strategy for the treatment of liver fibrosis.

Cytotoxic prenylated xanthone derivatives from the twigs of Garcinia cowa

A new prenylated xanthone, kaennacowanol D (1), was isolated from the twigs of Garcinia cowa together with 22 known analogs. The structure of the new metabolite was elucidated by extensive spectroscopic analysis, particularly using HRMS and NMR. Kaennacowanol D is the first example of a natural xanthone containing a levulinyl group incorporated at the terminal prenyl unit via ester bond. Cytotoxic evaluation of the isolated compounds on human cancer cells showed that jacareubin (13), 2-prenylisojacareubin (17), nigrolineaxanthone E (23) were significantly active against KB and Hela S3 cell lines with IC50 values ranging from 1.78 to 9.52 µM, while 17 and 23 also suppressed the growth of MCF-7, Hep G2, and HT-29 cells with IC50 values lower than 10 µM.

Preparation of dual drug-loaded polymer nanoconjugate to enhance treatment efficacy for ovarian cancer cells

Ovarian cancer is the deadliest gynecological malignancy, representing 2.5 % of all female cancers and accounting for 5 % of female cancer-related fatalities. Despite numerous strategies in its treatment, the disease shows a high recurrence rate and a low survival rate. Consequently, there is a growing focus on targeted therapies in ovarian cancer treatment. It is well-known that VEGFR and LPA pathways undergo alterations in ovarian cancer and stimulate survival, adhesion, migration, invasion, tumor growth and angiogenesis. Cabozantinib (CBZ) is a multi-receptor tyrosine kinase inhibitor that effectively targets MET, VEGFR-1, 2, 3, FLT3, c-KIT, and RET. Ki16425 is a selective inhibitor of LPA receptors 1, 2, and 3. Therefore, targeting LPA receptors and combining with VEGFR inhibitor is a strategic approach for ovarian cancer treatment. In this study, it was aimed to prepare polymer-drug nanoconjugate for both VEGFR and LPAR inhibition. For this, O-(2-Carboxyethyl) polyethylene glycol (PEG5000) which advantages are known in cancer studies, was chosen as the carrier system, and a nanoconjugate containing Ki16425 and CBZ (Ki-PEG-CBZ) was synthesized and its potential was evaluated. Initially, CBZ and Ki16425 were conjugated to the PEG5000 through pH-sensitive hydrazone and ester bonds. After nanoconjugate characterization, in vitro release and its ovarian cancer treatment potential were evaluated on A2780, OVCAR3 and SKOV3 ovarian cancer cell lines. A nanoconjugate was obtained with a particle size of 169 ± 15.23 nm, a zeta potential of −13.5 ± 1.21 mV, and a release profile lasting 48 h, containing CBZ and Ki16425 with drug loading efficiencies of 73.71 ± 0.53 % and 77.72 ± 2.51 %, respectively. In vitro studies have demonstrated that Ki-PEG-CBZ is highly effective against ovarian cancer. We suggest that the developed polymer-drug nanoconjugate is an effective and safe nanoconjugate for the treatment of ovarian cancer.

In Situ Chemical Mapping of the Thin-Film Lubricated Contact.

In this article, we propose a direct measurement of the distribution of two different chemical species in a thin-film lubricated contact under pure rolling conditions. The two chemical species were a carbonyl from an ester bond of a polyalphametacrylate (PAMA) polymer and an ether bond of a polyalphalycol (PAG) molecule, formulated in low-viscosity fluids using a mineral polyalphaolefin (PAO). A full chemical mapping of the lubricated contact region was provided thanks to the Bastet tribometer consisting of a ball-on-disk tribometer placed under a microscope coupled with an infrared spectrometer. By following the specific infrared stretching band of these two species in the inlet, contact, and cavitation areas, we showed how these molecules penetrate the high-pressure contact zone and participate in the film-formation.

Arylacetamide deacetylase regulates hepatic iron homeostasis to protect against carbon tetrachloride-induced ferroptosis.

Arylacetamide deacetylase (AADAC) catalyzes the hydrolysis of small molecules containing ester and amide bonds. Recently, it has been reported that AADAC can suppress reactive oxygen species production in cancer cells. This study aimed to elucidate the possibility that AADAC protects against drug-induced liver injury accompanied by oxidative stress and to explore its molecular mechanisms. Intraperitoneal administration of carbon tetrachloride induced significantly more severe liver injury in Aadac knockout (KO) mice (plasma alanine aminotransferase level: 19,381 ± 10,578 U/L) than in wild-type (WT) mice (7219 ± 4729 U/L). More severe liver injury in Aadac KO mice was accompanied by higher hepatic malondialdehyde and antioxidant gene mRNA levels than those in WT mice. The increase in plasma alanine aminotransferase levels in Aadac KO mice was substantially suppressed by pretreatment with the ferroptosis inhibitors deferoxamine or ferrostatin-1, suggesting that Aadac deficiency increases susceptibility to ferroptosis. Immunoprecipitation followed by proteomic analysis revealed that AADAC interacts with ceruloplasmin (CP), which oxidizes ferrous iron to ferric iron. Hepatic CP activity was significantly lower in Aadac KO mice than that in WT mice, resulting in elevated hepatic ferrous iron levels in Aadac KO mice. Overexpression of human AADAC in Huh-7 cells significantly attenuated carbon tetrachloride-induced cytotoxicity by suppressing ferrous iron accumulation, suggesting that AADAC interacts with CP to suppress hepatic ferrous iron accumulation. The hepatoprotective role of Aadac in ferroptosis was also observed in mice with acetaminophen-induced liver injury. This study demonstrates a novel function of AADAC in protecting against ferroptosis induced by hepatotoxicants, carbon tetrachlorideand acetaminophen.